Taro Pharmaceutical Industries Ltd.
FDA inspection history in Haifa, Israel, 2019
- 1
- Form 483
Every document, by year
- Form 483
2019: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2019One Form 483, at Haifa, Israel.
Cited most
Across all Taro Pharmaceutical Industries observations on file
- 21 CFR 211.192Production record review1
The complete Taro Pharmaceutical Industries file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Haifa, Israel
One Form 483 · 2019 · 1 observation
Latest: Form 483, Jul 11, 2019 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2019-07-11 | 483 Form 483 | Haifa, Israel | 1 | $99 |
FEI number 3002808385 · most recent document Jul 11, 2019
About Taro Pharmaceutical Industries Ltd.
How many FDA Form 483s has Taro Pharmaceutical Industries Ltd. received?
FDA Intel has 1 Form 483 on file for Taro Pharmaceutical Industries Ltd.; the most recent is dated Jul 11, 2019.
When was Taro Pharmaceutical Industries Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Taro Pharmaceutical Industries Ltd. is a Form 483 dated Jul 11, 2019, for the site in Haifa, Israel.
What did FDA cite at Taro Pharmaceutical Industries Ltd.?
The regulations cited most in the observations on file for Taro Pharmaceutical Industries Ltd. are 21 CFR 211.192 (Production record review), 1 time.